Sarepta Therapeutics
SRPT
#4840
Rank
โ‚น167.32 B
Marketcap
โ‚น1,594
Share price
2.19%
Change (1 day)
-76.92%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Earnings for Sarepta Therapeutics (SRPT)

Earnings in 2025 (TTM): -โ‚น22.12 Billion

According to Sarepta Therapeutics 's latest financial reports the company's current earnings are โ‚น2.41 Billion. In 2024 the company made an earning of โ‚น24.42 Billion, an increase over its 2023 earnings that were of -โ‚น48.72 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sarepta Therapeutics from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น22.12 Billion-190.54%
2024 โ‚น24.42 B-150.14%
2023 -โ‚น48.72 Billion-24.62%
2022 -โ‚น64.63 Billion64.69%
2021 -โ‚น39.25 Billion-24.25%
2020 -โ‚น51.81 Billion-22.53%
2019 -โ‚น66.87 Billion96.87%
2018 -โ‚น33.97 Billion645.68%
2017 -โ‚น4.56 Billion-81.81%
2016 -โ‚น25.04 Billion21.47%
2015 -โ‚น20.61 Billion62.04%
2014 -โ‚น12.72 Billion21.26%
2013 -โ‚น10.49 Billion60.93%
2012 -โ‚น6.52 Billion93.69%
2011 -โ‚น3.37 Billion71.58%
2010 -โ‚น1.97 Billion35.06%
2009 -โ‚น1.46 Billion-11.62%
2008 -โ‚น1.65 Billion-47.02%
2007 -โ‚น3.11 Billion0.38%
2006 -โ‚น3.09 Billion88.3%
2005 -โ‚น1.65 Billion-30.06%
2004 -โ‚น2.35 Billion32.69%
2003 -โ‚น1.77 Billion-25.52%
2002 -โ‚น2.38 Billion64.52%
2001 -โ‚น1.45 Billion50.4%
2000 -โ‚น0.96 Billion26.44%
1999 -โ‚น0.76 Billion8%
1998 -โ‚น0.71 Billion102.7%
1997 -โ‚น0.35 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
โ‚น925.97 B-4,020.12%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
โ‚น69.40 B-393.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น35.12 B-248.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น12.20 B-151.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Insmed
INSM
-โ‚น103.12 Billion 336.56%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น0.62 Billion-97.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-โ‚น51.5 Billion 118.01%๐Ÿ‡บ๐Ÿ‡ธ USA